Literature DB >> 11060301

Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression.

S Pal1, K Datta, R Khosravi-Far, D Mukhopadhyay.   

Abstract

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), a multifunctional cytokine, is regulated by different factors including degree of cell differentiation, hypoxia, and certain oncogenes namely, ras and src. The up-regulation of VPF/VEGF expression by Ras has been found to be through both transcription and mRNA stability. The present study investigates a novel pathway whereby Ras promotes the transcription of VPF/VEGF by activating protein kinase Czeta (PKCzeta). The Ras-mediated overexpression of VPF/VEGF was also found to be inhibited by using the antisense or the dominant-negative mutant of PKCzeta. In co-transfection assays, by overexpressing oncogenic Ha-Ras (12 V) and PKCzeta, there was an additive effect up to 4-fold in activation of Sp1-mediated VPF/VEGF transcription. It has been shown through electrophoretic mobility shift assay that Ras promoted the PKCzeta-induced binding of Sp1 to the VPF/VEGF promoter. In the presence of PDK-1, a major activating kinase for PKC, the Ras-mediated activation of VPF/VEGF promoter through PKCzeta was further increased, suggesting that PKCzeta can serve as an effector for both Ras and PDK-1. In other experiments, with the use of a dominant-negative mutant of phosphatidylinositol 3-kinase, the activation of VPF/VEGF promoter through Ras, PDK-1, and PKCzeta was completely repressed, indicating phosphatidylinositol 3-kinase as an important component of this pathway. Taken together, these data elucidate the signaling mechanism of Ras-mediated VPF/VEGF transcriptional activation through PKCzeta and also provide insight into PKCzeta and Sp1-dependent transcriptional regulation of VPF/VEGF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060301     DOI: 10.1074/jbc.M007818200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.

Authors:  Sutapa Sinha; Sayantani Roy; Bathula Surendar Reddy; Krishnendu Pal; Godeshala Sudhakar; Seethalakshmi Iyer; Shamit Dutta; Enfeng Wang; Pawan Kumar Vohra; Karnati Rammohan Roy; Pallu Reddanna; Debabrata Mukhopadhyay; Rajkumar Banerjee
Journal:  Mol Cancer Res       Date:  2011-02-02       Impact factor: 5.852

2.  Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.

Authors:  Aninda Basu; Tao Liu; Pallavi Banerjee; Evelyn Flynn; David Zurakowski; Dipak Datta; Ondrej Viklicky; Martin Gasser; Ana Maria Waaga-Gasser; Jun Yang; Soumitro Pal
Journal:  Cancer Lett       Date:  2012-02-14       Impact factor: 8.679

3.  Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K, and PKCzeta in THP-1 cells.

Authors:  Carmen W Dessauer; Bao T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

4.  In vitro footprinting of promoter regions within supercoiled plasmid DNA.

Authors:  Daekyu Sun
Journal:  Methods Mol Biol       Date:  2010

5.  Differential effects of shear stress and cyclic strain on Sp1 phosphorylation by protein kinase Czeta modulates membrane type 1-matrix metalloproteinase in endothelial cells.

Authors:  Ji Il Kim; Alfredo C Cordova; Yo Hirayama; Joseph A Madri; Bauer E Sumpio
Journal:  Endothelium       Date:  2008 Jan-Feb

6.  Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.

Authors:  Dipak Datta; Alan G Contreras; Aninda Basu; Olivier Dormond; Evelyn Flynn; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

7.  Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor.

Authors:  Sirisha Emani; Basel Ramlawi; Neel R Sodha; Jian Li; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-13       Impact factor: 5.209

8.  Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

Authors:  C Mahanivong; H M Chen; S W Yee; Z K Pan; Z Dong; S Huang
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

9.  Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

Authors:  Akihiro Takahashi; Yasuko Kureishi; Jiang Yang; Zhengyu Luo; Kun Guo; Debabrata Mukhopadhyay; Yuri Ivashchenko; Didier Branellec; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents.

Authors:  Daekyu Sun; Wei-Jun Liu; Kexiao Guo; Jadrian J Rusche; Scot Ebbinghaus; Vijay Gokhale; Laurence H Hurley
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.